by Doug LaRocca | Apr 26, 2019 | Central Compounding Pharmacy, LDN Articles
Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.AbstractFibromyalgia is a chronic pain disorder that is characterized by diffuse musculoskeletal pain and sensitivity to mechanical stimulation…. click here for more.Source:...
by Doug LaRocca | Apr 26, 2019 | Central Compounding Pharmacy, LDN Articles
Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn’s disease: a pilot study.AbstractThere is an unmet need for safe and effective medicines to treat children with Crohn’s disease… click here for...
by Doug LaRocca | Feb 25, 2019 | Central Compounding Pharmacy, LDN Articles
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain SyndromesAbstractPain can have a devastating effect on the quality of life of patients in palliative medicine… click here for more.Source:...
